Nicotine Replacement Therapy Market to hit USD 4.27 Billion by 2032, at a CAGR of 4.83%.

The nicotine replacement therapy (NRT) market is propelled by a global push towards reducing tobacco consumption, driven by comprehensive health initiatives and public health policies. The World Health Organization (WHO) reports that tobacco use is a major public health crisis, causing around 8 million deaths each year from smoking-related illnesses. This alarming statistic underscores the urgent need for effective smoking cessation tools. In the United States, the Centers for Disease Control and Prevention (CDC) reveals that more than half of smokers express a strong desire to quit, and approximately 30% are actively seeking assistance through various cessation aids. This heightened awareness about the health risks of smoking and the effectiveness of cessation products is contributing to the growing demand for NRT solutions.